No 2022:3: Health Technology Assessment (HTA) of GLP-1 receptor agonists and SGLT-2 inhibitors in combination with metformin as first-line treatment in patient with type 2 diabetes mellitus (T2DM) and established cardiovascular or chronic kidney disease
Eline Aas, Monica Gomez and Fawaz Tariq
No 2022:2: Resultatevaluering av Omsorg 2020 – regjeringens plan for omsorgsfeltet 2015–2020
Trond Tjerbo, Oddvar Førland, Jardar Sørvoll, Terje P. Hagen, Rina Moe Fosse, et al.
No 2022:1: Sending emails to reduce medical costs? The effect of feedback on general practitioners’ claiming of fees
Ole Kristian Aars, Geir Godager, Oddvar Kaarboe and Tron Anders Moger
Questions (including download problems) about the papers in this series should be directed to Kristi Brinkmann Lenander ()
Report other problems with accessing this service to Sune Karlsson ().
This page generated on 2024-09-13 22:16:49.